Hagerty Jumps 25% in a Month as Analysts Chase the Stock Higher

HGTY has had a sharp run, up 25% over the past month and 9.4% on the week alone, and the analyst community is now rushing to catch up with a price that has already moved past several of their targets.

The clearest story this week is on the analyst side. Three firms lifted their targets on November 4, all maintaining existing ratings rather than upgrading. Truist Securities raised its target from $13 to $16 while keeping a Hold. Wells Fargo moved from $14 to $17 on an Equal-Weight. Citizens went furthest, lifting to $19 from $15 on a Market Outperform. With the stock closing at $17.03, Wells Fargo's new target is already essentially in the money, and Truist's Hold remains below the current price. The consensus is still a Hold with a mean target of $14.50, a figure that now looks stale given the recent move, and four analysts collectively have not yet revisited that average. The direction of travel is unambiguously upward revision, but ratings have not followed suit, leaving a gap between where analysts think the stock belongs and where it trades.

Fundamentals help explain the price action. EPS momentum ranks in the 99th percentile on a 30-day basis and 100th percentile on 90 days. EPS surprise is in the 99th percentile. Forward earnings estimates have been revised sharply higher. The EV/EBITDA multiple has expanded over the past month, rising by roughly 0.22 turns to 4.95x, and the price-to-book ratio has climbed by 1.1 turns over the same period to 6.3x. The ORTEX short score has also eased, falling from around 41 two weeks ago to 37.1 now, a move consistent with weakening conviction on the bear side as the stock has re-rated.

Positioning carries no meaningful friction for bulls. Short interest is just 1.3% of the free float and fell a further 2.3% on the week. Borrowing is cheap at 0.57% annualised. Availability is extremely loose at nearly 983%, meaning lenders are sitting on roughly ten shares available to borrow for every one already out on loan. Options sentiment is neutral and stable, with the put/call ratio at 0.45, essentially flat against its 20-day average of 0.45 and nowhere near the 52-week defensive extreme of 0.85. There is no short pressure building, no squeeze dynamic, and no options hedging rush. The stock's move is being driven by fundamentals and re-rating, not by short covering.

Ownership is dominated by a small number of large holders, and the activist register is worth noting. Three filers carry Schedule 13D status: Hagerty Holding Corp., Markel Group, and State Farm Mutual. All three are insiders in the economic sense, holding large strategic stakes rather than taking positions with intent to push for change. Hagerty Holding Corp. filed a 13D/A in September, disclosing a reduction from 62.4% to 56.5% of class, with roughly 10.6 million net shares leaving insider hands over the trailing 90 days at prices around $11.47. That selling happened well below current levels. Neuberger Berman, the largest purely institutional holder outside the founding group, added 1.5 million shares in the quarter to September 30, bringing its position to 11.1 million shares or about 10.8% of the total. T. Rowe Price also added in the same period. As always with 13D/G filings, stakes reflect last-disclosed positions and holders who drop below 5% are not required to notify the market again.

Retail attention has also picked up. Wikipedia page views for Hagerty are running at a z-score of 1.87 against the company's own 90-day history, suggesting above-average traffic compared with what is typical for the name. This is an attention signal rather than a revenue indicator, but it tracks with the stock's recent visibility after a sharp move.

The next earnings date is not until February 23, 2027, leaving over three months before the next hard catalyst. What to watch from here is whether the Hold-rated analysts at Truist, Wells Fargo and JPMorgan move to upgrade now that their targets have been absorbed by the price, and whether the EPS estimate revisions that drove the factor scores continue to broaden.